Harpoon Therapeutics Email Formats

Pharmaceutical Manufacturing • South San Francisco, California, United States • 21-50 Employees

Harpoon Therapeutics Email Formats

Harpoon Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	45.6%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	22.3%
{first name}@company.com	john@company.com	15.1%
{first name}{last name}@company.com	johndoe@company.com	9.8%
{first name}_{last name}@company.com	john_doe@company.com	7.2%

Key Contacts at Harpoon Therapeutics

Grace Wang

Director, Tm Operations

Patrick P. Ng

Senior Director Of Translational Medicine

Mark Wesson

Director, Cmc Outsourcing

Company overview

Headquarters	611 Gateway Blvd., Suite 400, South San Francisco, California 94080, US
Website	harpoontx.com
NAICS	3254
Founded	2015
Employees	21-50

About Harpoon Therapeutics

Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct (TriTAC®) platform, Harpoon is developing a pipeline of novel TriTACs initially focused on the treatment of solid tumors and hematologic malignancies. Harpoon has also developed a proprietary ProTriTAC™ platform, which applies a prodrug concept to its TriTAC platform to create a therapeutic T cell engager that remains inactive until it reaches the tumor. Harpoon’s third proprietary technology platform, extended release TriTAC-XR, is designed to mitigate cytokine release syndrome. For more information, please visit www.harpoontx.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager

Director

Entry

Employees by Department

Harpoon Therapeutics has 6 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Harpoon Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-11-23	14	$100,000,000

Funding Insights

$100,000,000

Total funding amount

$100,000,000

Most recent funding amount

Number of funding rounds

Harpoon Therapeutics Tech Stack

Discover the technologies and tools that power Harpoon Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

UserWay

Accessibility

Google Tag Manager

Tag managers

jQuery

JavaScript libraries

HSTS

Security

Vimeo

Video players

Google Analytics

Analytics

OneTrust

Cookie compliance

Prototype

JavaScript frameworks

Microsoft 365

Frequently asked questions

Harpoon Therapeutics is located in South San Francisco, California, US.

Harpoon Therapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Harpoon Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Harpoon Therapeutics has raised a total of $100,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.